An expert committee of the Central Drugs Standard Control Organisation (CDSCO) is scheduled to meet on Wednesday (December 9) to review applications for the ememrgency-use approval of the Covid-19 vaccine developed by Pfizer, Serum Institute of India and Bharat Biotech. Watch the video for more information.
